A Study of KF-0210 in Advanced Solid Tumors Patients
Phase 1
- Conditions
- Squamous Cell Carcinoma of the EsophagusAdvanced Solid TumorColorectal CancerLung CancerGastric CancerBladder Cancer
- Interventions
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Keythera Pharmaceuticals (Australia) Pty Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT04713891
- Locations
- 🇦🇺
Scientia Clinical Research Limited, Randwick, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath